With election season around the corner, Google and YouTube are keeping a close eye on

A U.S. antitrust regulator said on Tuesday it will sue to stop Amgen's $27.8 billion deal for Horizon

BRUSSELS Short video app TikTok said on Sunday it had immediately mobilised resources and personnel to counter hate

LONDON--(BUSINESS WIRE)--Jun 14, 2023--

Republican lawmakers are planning to cut funding for University of Wisconsin campuses as the GOP-controlled state Legislature and school officials continue to clash over efforts to promote diversity and inclusion

ORLANDO, Fla.--(BUSINESS WIRE)--Aug 9, 2023--

(Corrects to remove erroneous Refinitiv Instrument Code) (Reuters) -Cryptocurrency exchange Kraken said on Sunday that issues with cryptocurrency Ethereum's funding

LONDON--(BUSINESS WIRE)--Sep 20, 2023--

Prime Minister Justin Trudeau criticized Meta Platforms Inc.’s blocking of news content, saying it impedes information sharing during

Our canine companions could soon be enjoying much longer lifespans, if a drug which claims it can extend dogs’ lives eventually gets approved. The drug, made by a tech firm in California, just cleared a vital hurdle to doing just that, after it got partial approval by regulators in the US. Loyal, a San Francisco-based company founded in 2020, has been researching how it can increase dogs’ lifespans – in particular larger breeds, which tend to die younger. Large and “giant” breeds tend to live to between eight and 12 years. Smaller dogs, such as Chihuahuas, can keep going to the ripe old age of 20. Loyal’s main product, the catchily-titled LOY-001, is designed not only to extend dogs’ lives but also maintain their quality of life. Now, it has passed the “reasonable expectation of effectiveness” test, set by regulators at the US’ Food and Drug Administration. Loyal’s chief executive, Celine Halioua, said: "Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs. "This milestone is the result of years of careful work by the team. We'll continue to work just as diligently to bring this and our other longevity programs through to FDA approval." Selective breeding of dogs has caused higher levels of hormones which help the animals grow faster. That is also believed to reduce their lifespan, the company said. Big dogs tend to have more of this hormone than their smaller counterparts. Animal rights activists are not yet convinced. Some experts fear it will only serve to extend animals’ suffering. Loyal, on the other hand, says the drug aims to treat doggy diseases which are associated with ageing through preventing them, rather than waiting for the animals to get sick before treating them. The company said that the drug could be available to US customers as early as 2026. So that’s plenty of time for walkies between now and then. How to join the indy100's free WhatsApp channel Sign up to our free indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

NEW YORK & TEL AVIV--(BUSINESS WIRE)--Sep 6, 2023--

'GMA' host Michael Strahan responds with brutal clapback after troll attacks Harry Kane's 'Football and soccer' post